[1]李亚锋,袁林,马慧,等.从脾论治腰椎间盘突出症的临床观察[J].中国中医骨伤科杂志,2023,31(09):27-31.[doi:10.20085/j.cnki.issn1005-0205.230905 ]
　LI Yafeng,YUAN Lin,MA Hui,et al.Clinical Observation on the Treatment of Lumbar Disc Herniation from Spleen[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2023,31(09):27-31.[doi:10.20085/j.cnki.issn1005-0205.230905 ]
点击复制

从脾论治腰椎间盘突出症的临床观察()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第31卷
期数:
2023年09期
页码:
27-31
栏目:
临床研究
出版日期:
2023-09-15

文章信息/Info

Title:
Clinical Observation on the Treatment of Lumbar Disc Herniation from Spleen
文章编号:
1005-0205(2023)09-0027-05
作者:
李亚锋1; 袁林1; 马慧1; 杨浩田1; 贾育松2△
1北京中医药大学东直门医院(北京,100007) 2清华大学中西医结合医院
Author(s):
LI Yafeng1; YUAN Lin1; MA Hui1; YANG Haotian1; JIA Yusong2△
1Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100007,China; 2Tsinghua University Hospital of Integrated Traditional Chinese and Western Medicine,Beijing 100049,China.
关键词:
从脾论治;  健脾化痹方;  腰椎间盘突出症;  中药
Keywords:
treating from the spleen;  Jianpi Huabi decoction;  lumbar disc herniation;  traditional Chinese medicine
分类号:
R681.5
DOI:
10.20085/j.cnki.issn1005-0205.230905
文献标志码:
A
摘要:
目的:基于从脾论治腰椎间盘突出症的思路,评价健脾化痹方治疗腰椎间盘突出症(脾虚湿滞证)的有效性和安全性。方法:选取50例腰椎间盘突出症(脾虚湿滞证)患者,采取随机数字表法随机分为观察组和对照组,每组25例; 观察组予健脾化痹方口服,对照组予洛索洛芬钠片口服,连续治疗4周。对比治疗前后及3个月后数字等级评定量表(NRS)疼痛评分、EuroQol 5维问卷5级量表(EQ-5D-5L)评分、Oswestry功能障碍指数(ODI)评分、健康调查简表(SF-36)评分及中医疗效变化情况,同时记录不良事件发生情况。结果:观察组腰痛、臀痛NRS评分、EQ-5D-5L效应指数值、ODI评分及SF-36总评分相比治疗前有明显改善,差异有统计学意义(P<0.05); 对照组躯体健康(PCS)评分相比治疗前有明显改善,差异有统计学意义(P<0.05)。随访3个月观察组NRS评分、EQ-5D-5L评分、ODI评分及SF-36评分相比治疗前明显改善,差异有统计学意义(P<0.05)。对照组除臀痛NRS评分及精神健康(MCS)评分外其他评分相比治疗前明显改善,差异有统计学意义(P<0.05)。中医疗效方面,治疗后观察组和对照组总有效率分别为88%和64%,随访3个月观察组和对照组总有效率分别为92%和68%,两组之间差异有统计学意义(P<0.05)。结论:基于从脾论治腰椎间盘突出症的理念,健脾化痹方可有效改善腰椎间盘突出症(脾虚湿滞证)患者的疼痛、腰椎功能、生存质量及中医证候。
Abstract:
Objective:To evaluate the efficacy and safety of Jianpi Huabi decoction in treating lumbar disc herniation(spleen deficiency and dampness stagnation syndrome)based on the concept of treating lumbar disc herniation from the spleen.Methods:50 patients with lumbar intervertebral protrusion(syndrome of spleen deficiency and dampness stagnation)were randomly divided into an observation group and a control group,with 25 cases in each group.Jianpi Huabi decoction was taken in the observation group,and losuprofin sodium tablets were taken orally for 4 weeks in the control group.The changes of numerical rating scale(NRS)pain score,EQ-5D-5L score,Oswestry disability index(ODI)score,SF-36 score,and traditional Chinese medicine efficacy before,after treatment and 3 months later were compared.The occurrence of adverse events were documented.Results:The NRS pain score,EQ-5D-5L efficacy index,ODI score,and SF-36 total score of the observation group patients showed significant improvement compared to before treatment(P<0.05).The physical component summary(PCS)score of the control group patients showed significant improvement compared to before treatment(P<0.05).After 3 months,the NRS pain score,EQ-5D-5L score,ODI score,and SF-36 score of the observation group patients showed significant improvement compared to before treatment(P<0.05).The control group showed significant improvement in all scores except for the NRS score and mental component summary(MCS)score of buttock pain compared to before treatment(P<0.05).In terms of traditional Chinese medicine efficacy,the total effective rates of the observation group and the control group after treatment were 88% and 64%,respectively.After 3 months,the total effective rates of the observation group and the control group were 92% and 68%,respectively,with statistical significance between the two groups(P<0.05).Conclusion:Jianpi Huabi decoction can effectively improve the pain,lumbar dysfunction,quality of life and TCM syndrome of patients with LDH(spleen deficiency dampness stagnation syndrome)based on the concept of treating LDH from the spleen.

参考文献/References:

[1] 中华医学会疼痛学分会脊柱源性疼痛学组.腰椎间盘突出症诊疗中国疼痛专家共识[J].中国疼痛医学杂志,2020,26(1):2-6.
[2] 中华医学会骨科学分会脊柱外科学组,中华医学会骨科学分会骨科康复学组.腰椎间盘突出症诊疗指南[J].中华骨科杂志,2020(8):477-487.
[3] LUO Y,HUANG J,XU L,et al.Efficacy of Chinese herbal medicine for lumbar disc herniation:a systematic review of randomized controlled trials[J].J Tradit Chin Med,2013,33(6):721-726.
[4] ZHANG B,XU H,WANG J,et al.A narrative review of non-operative treatment,especially traditional Chinese medicine therapy,for lumbar intervertebral disc herniation[J].Biosci Trends,2017,11(4):406-417.
[5] SUN K,HUANG F,QI B,et al.A systematic review and meta-analysis for Chinese herbal medicine Duhuo Jisheng decoction in treatment of lumbar disc herniation:a protocol for a systematic review[J].Medicine(Baltimore),2020,99(9):e19310.
[6] LI X,HAN Y,CUI J,et al.Efficacy of warm needle moxibustion on lumbar disc herniation:a meta-analysis[J].J Evid Based Complementary Altern Med,2016,21(4):311-319.
[7] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002:361-364.
[8] 国家中医药管理局.中医病证诊断疗效标准[S].南京:南京大学出版社,1994:201.
[9] 刘静,谢兴文,王春晓,等.从脏腑辨证论述腰椎间盘突出症的研究进展[J].中国医药科学,2022,12(3):55-58.
[10] 刘明达,王旭凯,周锐,等.基于中医辨证综合治疗腰椎间盘突出症研究进展[J].河北中医,2021,43(6):1033-1037.
[11] 高宏伟,李守超,吕邵娃.中药治疗腰椎间盘突出症临床研究进展[J].辽宁中医药大学学报,2021,23(3):98-102.
[12] 杨少锋,郭彦涛,罗振华,等.长沙市腰椎间盘突出症中医证候研究[J].中医正骨,2016,28(2):33-35.
[13] 袁林,李亚锋,赵学千,等.基于“脾为后天之本”理论从脾论治腰椎退行性疾病的理论探讨[J].中医正骨,2021,33(8):46-48.
[14] 徐贞官,陈诗雅,韦贵康,等.腰椎间盘突出症与中医“脾土”的关系[J].广西中医药,2009,32(6):24-25.
[15] 赖永德.探讨肝肾虚、脾困湿与腰椎间盘突出症的发生[J].四川中医,2010,28(4):31-32.
[16] 储诚煜,王峰,张建华,等.经椎间孔椎体间融合术联合加味补中益气汤治疗腰椎间盘突出症临床观察[J].安徽中医药大学学报,2020,39(4):31-34.
[17] 曹建恒.补中益气汤加味治疗腰椎间盘突出症52例[J].陕西中医,2005(4):328-329.
[18] 闵文,成舟,谭峰,等.加味肾着汤治疗寒湿型腰椎间盘突出症的临床观察[J].中华中医药杂志,2018,33(11):5239-5242.
[19] 霍晨露,宋欣怡,李慧,等.基于肾着汤探究从脾论治寒湿型腰椎间盘突出症[J].风湿病与关节炎,2021,10(4):49-52.

备注/Memo

备注/Memo:
基金项目:国家中医药管理局中医药循证能力建设项目(2019X22X-GK005)
国家重点研发计划腰椎间盘突出症中医方案的临床评价(2021YFC1712802)
△通信作者 E-mail:jiayusong1970@163.com
更新日期/Last Update: 2023-09-01